Pfizer Inc. (PFE) this week proposed the biggest such deal yet, a $98.7 billion takeover ofAstraZeneca Plc (AZN) that would move the largest U.S. drugmaker to the U.K. for tax purposes and lower its tax rate.
“We’ve done, I think, probably all we can within the statute,” Koskinen, 74, told reporters inWashington today, saying the trend of corporate moves point up the need to revise the U.S. tax code. “We try to make sure people are within the bounds, but if they’re within the bounds, if they play according to the rules, then they have a right to do that.”
Koskinen’s remarks show the limits of the government’s ability to respond without Congress and suggest that the Obama administration won’t make a regulatory move to stop or limit so-called corporate inversions.
Pfizer would join at least 19 other companies making or contemplating similar transactions, includingChiquita Brands International (CQB) Inc. and Omnicom Group (OMC) Inc., the largest U.S. advertising firm.
http://www.bloomberg.com/news/2014-0...ing-moves.html


Reply With Quote
